Neutrophil infiltration is a hallmark of pulmonary inflammation during respiratory viral infections, yet the origin of these cells has been a subject ...

Severe COVID-19 and influenza infections can epigenetically reprogram lung and immune cells, creating a pro‑tumor environment that increases lung cancer risk, but vaccines may prevent this.

The updated 2024-2025 mRNA COVID-19 vaccine was linked to moderate protection against severe COVID-19 outcomes, including hospitalizations.

People hospitalised with severe COVID-19 had a 24 per cent higher risk ...

An analysis of 76 million people found that those who had been ill with Covid were at greater risk of developing one cancer ...

Those who have contracted Covid could be at an increased risk of lung cancer, scientists have found. The research indicates ...

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a respiratory illness with systemic immune cell activation, inflammation, widespread multiorgan dysfunction, and thrombosis.

COVID-19 vaccination during pregnancy may lower the risk for preeclampsia and other complications, according to new data.The findings “support the importance of strengthening COVID vaccination ...

Severe COVID-19 raises lung cancer risk by 24%, study of 76 million Americans finds In A Nutshell People hospitalized with severe COVID-19 had roughly a 24 percent higher risk of developing lung ...

Severe COVID-19 and influenza infections prime the lungs for cancer and can accelerate the disease's development, but vaccination heads off those harmful effects, new research from UVA Health's Beirne ...

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, ...